Aclaris Therapeutics Inc buy krebskrebs
Start price
17.04.24
/
50%
€1.14
Target price
17.04.25
€3.00
Performance (%)
-9.93%
End price
18.04.25
€1.03
Summary
This prediction ended on 18.04.25 with a price of €1.03. With a performance of -9.93%, the BUY prediction by krebskrebs finished with a loss. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aclaris Therapeutics Inc | 14.092% | 14.092% | -8.259% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by krebskrebs for this prediction
In the thread Aclaris Therapeutics Inc diskutieren
In the thread Trading Aclaris Therapeutics Inc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten